Greywolf Therapeutics
greywolftherapeutics.com
Actively hiring
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
501-1000
employees, estimated range
Backers
1
Canaan
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2017
Founded
Registers and programsofficial lists and records that name the company
| Legal entity | Introduction Grey Wolf Therapeutics Limited | its site |
| Registered | 29 Sep 2017 |
Backed byfrom the funds' portfolios and accelerator catalogs
Canaan Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Onyx is a research collective of citizens and scientists building a virtual cell to better understand the immune system.
FROM CELLS TO ORGANELLES• ORGANELLES•. First-in-Class Isolated Organelles for Drug Discovery.
Unlocking the potential of the immune system. IMU.
FIRST-IN-CLASS SUPERIOR MAST CELL THERAPEUTICS. First-in-Class Superior Mast Cell Therapeutics targeting mast cells in major diseases areas…
Targeting cells to treat disease. 1030 Brittan Ave, San Carlos, CA 94070.
ProTgen develops first-in-class targeted Notch activators that generate progenitor T cells to restore thymic function and immune competence.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Abingdon
United Kingdom
HQ
Registered office
500-1000 est. staff
99 Park Drive, Milton Park,, Abingdon, OX14 4RY, UK